Immune profiling of mpox survivors reveals divergent durability of antibody and T cell responses

Y Yanqun Wang R Ruoxi Cai A Airu Zhu J Jiantao Chen (State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University) C Canjie Chen L Lijuan Zhou X Xindan Xing Q Qier Zhong P Peilan Wei X Xinxin Li (College of Chemistry, Zhengzhou University, Zhengzhou 450001, P. R. China) Z Zhaoyong Zhang Y Yuanyuan Zhang L Lei Chen J Jingjing Gao S Suxiang Li X Xinyi Xiong B Bin Qu S Shuxiang Huang Z Zhiwei Lin H Haoshi Bai Q Qingtao Hu J Jingxian Zhao Y Yongxia Shi Y Yang Yang P Pengzhe Qin L Lu Zhang J Jincun Zhao (Guangzhou National Laboratory)

Abstract

Abstract Despite the global spread of mpox virus (MPXV), the durability and breadth of infection-induced immunity remain incompletely defined. Here, we comprehensively characterize MPXV-specific antibody and T cell responses up to 18 months after natural infection in male individuals. Neutralizing antibodies exhibit typical acute viral kinetics, with titers peaking early and declining over time, from a mean of 328 at 12 months to 180 at 18 months post-infection. Neutralization analyses against MPXV clade Ib, clade IIb and VACV WR strains demonstrate pronounced cross-neutralization among orthopoxviruses, but with lineage-specific reductions in neutralization, indicating incomplete cross-reactivity across different lineages. In parallel, MPXV-specific CD4⁺ and Tfh cell responses remain robust and polyfunctional throughout follow-up, and CD8⁺ T cells maintain sustained responses characterized by cytokine production, together supporting durable cellular immunity. These findings offer critical insights into the durability and breadth of post-infection immunity, with implications for reinfection risk and orthopoxvirus vaccine strategies.

Article Details

Volume / Issue Vol. 17, Issue 1
Published December 04, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (27)

Y

Yanqun Wang

R

Ruoxi Cai

A

Airu Zhu

J

Jiantao Chen

State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University

C

Canjie Chen

L

Lijuan Zhou

X

Xindan Xing

Q

Qier Zhong

P

Peilan Wei

X

Xinxin Li

College of Chemistry, Zhengzhou University, Zhengzhou 450001, P. R. China

Z

Zhaoyong Zhang

Y

Yuanyuan Zhang

L

Lei Chen

J

Jingjing Gao

S

Suxiang Li

X

Xinyi Xiong

B

Bin Qu

S

Shuxiang Huang

Z

Zhiwei Lin

H

Haoshi Bai

Q

Qingtao Hu

J

Jingxian Zhao

Y

Yongxia Shi

Y

Yang Yang

P

Pengzhe Qin

L

Lu Zhang

J

Jincun Zhao

Guangzhou National Laboratory